Overview
- Legal name
- BIOSKRYB GENOMICS, INC.
- Registered location
- DURHAM, NC, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Feb 19, 2026
Read company summary
BIOSKRYB GENOMICS, INC. is associated with UEI MXN7X2RBZEN7 and CAGE 87E85 in public federal records. AcornBids currently links 3 prime awards totaling $77.8K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists DURHAM, NC, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 19, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BIOSKRYB GENOMICS, INC.
- UEI
- MXN7X2RBZEN7
- CAGE
- 87E85
- Registered address
- 2810 MERIDIAN PKWY STE 110, DURHAM, NC, 27713, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Dec 2, 2025
- Initial registration
- Jul 19, 2024
- Entity start
- Sep 23, 2019
- SAM updated
- Dec 2, 2025
- Registration expires
- Dec 1, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 3 awards and $77,822 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 3 of 3 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $29.0K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $48.8K |
| Change | $-19.8K |
| Growth | -40.5% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $77.8K | 3 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NHLBI | $48.8K | 2 |
| NATIONAL INSTITUTES OF HEALTH OLAO | $29.0K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $77.8K | 3 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $48.8K | 2 |
| 6640 — Laboratory Equipment and Supplies | $29.0K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $77.8K | 3 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NC | $77.8K | 3 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $52.8K | 2 |
| SMALL BUSINESS SET ASIDE - TOTAL | $25.0K | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N98026P00014SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME | Department of Health and Human Services | $29.0K | Feb 23, 2026 | Jun 10, 2026 |
| 75N92025P00360[25-014107] NIH NHLBI HEMATOPOIESIS AND BONE MARROW FAILURE LABORATORY REQUIRES STREAMLINE ANALYSIS OF SCWGS IN ORDER TO PHYLOGENETIC TREE RECONTRUCTION. | Department of Health and Human Services | $23.8K | Sep 8, 2025 | Nov 8, 2025 |
| 75N92025P00297[25-012460] THE LAB REQUIRES REAGENTS FOR SINGLE CELL WGS IN ORDER TO PHYLOGENETIC TREE ANALYSIS. | Department of Health and Human Services | $25.0K | Aug 4, 2025 | Nov 3, 2025 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 2, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jul 19, 2024 |
| Entity start | Sep 23, 2019 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| VICTOR WEIGMAN | Government business | Contact method not published | SAM registration | Not available |
| VICTOR WEIGMAN | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit